114 related articles for article (PubMed ID: 35338237)
1. Long-term longitudinal evaluation of the prevalence of SARS-CoV-2 antibodies in healthcare and university workers.
Huynen P; Grégoire C; Gofflot S; Seidel L; Maes N; Vranken L; Delcour S; Moutschen M; Hayette MP; Kolh P; Melin P; Beguin Y
Sci Rep; 2022 Mar; 12(1):5156. PubMed ID: 35338237
[TBL] [Abstract][Full Text] [Related]
2. Epidemiological study using IgM and IgG antibody titers against SARS-CoV-2 in The University of Tokyo, Japan (UT-CATS).
Mitani A; Hamada K; Yoshikawa N; Morita Y; Horie T; Inoue Y; Saito M; Ishii T; Sunohara M; Takahashi R; Emoto N; Nishimoto N; Murano Y; Okazaki S; Tateishi S; Yao A; Shimura T; Kurano M; Yatomi Y; Yanagimoto S
J Infect Chemother; 2021 Sep; 27(9):1342-1349. PubMed ID: 34158239
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of Health Care and Hospital Worker SARS-CoV-2 IgG Antibody in a Pediatric Hospital.
Tokareva Y; Englund JA; Dickerson JA; Brown JC; Zerr DM; Walter E; Tsogoo A; Cappetto K; Valdez Gonzalez J; Strelitz B; Klein EJ
Hosp Pediatr; 2021 Mar; 11(3):e48-e53. PubMed ID: 33361400
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of SARS-CoV-2 infection and dynamics of antibodies response among previously undiagnosed healthcare workers in a university hospital: A prospective cohort study.
Musa S; Abdel Alem S; Amer K; Elnagdy T; Hassan WA; Ali MA; Gaber Y; Badary HA; Tantawi O; Abdelmoniem R; Radwan A; Yousof H; Shawky S; Talaat H; Fouad R; Kassem AM
J Infect Public Health; 2021 Oct; 14(10):1466-1473. PubMed ID: 34175238
[TBL] [Abstract][Full Text] [Related]
5. Kinetics of SARS-CoV-2 Specific and Neutralizing Antibodies over Seven Months after Symptom Onset in COVID-19 Patients.
Zhu L; Xu X; Zhu B; Guo X; Xu K; Song C; Fu J; Yu H; Kong X; Peng J; Huang H; Zou X; Ding Y; Bao C; Zhu F; Hu Z; Wu M; Shen H
Microbiol Spectr; 2021 Oct; 9(2):e0059021. PubMed ID: 34550000
[TBL] [Abstract][Full Text] [Related]
6. Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workers.
Jackson-Thompson BM; Goguet E; Laing ED; Olsen CH; Pollett S; Hollis-Perry KM; Maiolatesi SE; Illinik L; Ramsey KF; Reyes AE; Alcorta Y; Wong MA; Davies J; Ortega O; Parmelee E; Lindrose AR; Moser M; Graydon E; Letizia AG; Duplessis CA; Ganesan A; Pratt KP; Malloy AM; Scott DW; Anderson SK; Snow AL; Dalgard CL; Powers JH; Tribble D; Burgess TH; Broder CC; Mitre E
BMC Infect Dis; 2021 Jun; 21(1):544. PubMed ID: 34107889
[TBL] [Abstract][Full Text] [Related]
7. Interpretations of SARS-CoV-2 IgM and IgG antibody titers in the seroepidemiological study of asymptomatic healthy volunteers.
Mitani A; Horie T; Yokoyama R; Nakano Y; Hamada K; Inoue Y; Saito M; Ishii T; Sunohara M; Takahashi R; Usui T; Emoto N; Nishimoto N; Murano Y; Okazaki S; Tateishi S; Iwasawa K; Yao A; Kurano M; Yatomi Y; Yanagimoto S
J Infect Chemother; 2022 Feb; 28(2):266-272. PubMed ID: 34887175
[TBL] [Abstract][Full Text] [Related]
8. Predictive factors for the presence and long-term persistence of SARS-CoV-2 antibodies in healthcare and university workers.
Grégoire C; Huynen P; Gofflot S; Seidel L; Maes N; Vranken L; Delcour S; Moutschen M; Hayette MP; Kolh P; Melin P; Beguin Y
Sci Rep; 2022 Jun; 12(1):9790. PubMed ID: 35697828
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of Sars-Cov-2 Infection in Health Workers (HWs) and Diagnostic Test Performance: The Experience of a Teaching Hospital in Central Italy.
Lahner E; Dilaghi E; Prestigiacomo C; Alessio G; Marcellini L; Simmaco M; Santino I; Orsi GB; Anibaldi P; Marcolongo A; Annibale B; Napoli C
Int J Environ Res Public Health; 2020 Jun; 17(12):. PubMed ID: 32575505
[TBL] [Abstract][Full Text] [Related]
10. Large-scale IgM and IgG SARS-CoV-2 serological screening among healthcare workers with a low infection prevalence based on nasopharyngeal swab tests in an Italian university hospital: Perspectives for public health.
Vimercati L; Stefanizzi P; De Maria L; Caputi A; Cavone D; Quarato M; Gesualdo L; Lopalco PL; Migliore G; Sponselli S; Graziano G; Larocca AMV; Tafuri S
Environ Res; 2021 Apr; 195():110793. PubMed ID: 33508260
[TBL] [Abstract][Full Text] [Related]
11. [The prevalence rate of anti-SARS-CoV-2-IgG is 1.2% - Screening in asymptomatic outpatients in Germany (Northrhine-Westfalia)].
Herrmann BL
MMW Fortschr Med; 2020 Aug; 162(14):44-46. PubMed ID: 32780376
[TBL] [Abstract][Full Text] [Related]
12. Highlighted Prospects of an IgM/IgG Antibodies Test in Identifying Individuals With Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.
Li Y; He Q; Yu R; Jiang H; Wang W; Feng D; Hou G; Zhou H; Jiang Y; Xiang Z
Arch Pathol Lab Med; 2021 Jan; 145(1):39-45. PubMed ID: 32966561
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of IgG antibodies against SARS-CoV-2 among healthcare workers in a tertiary pediatric hospital in Poland.
Kasztelewicz B; Janiszewska K; Burzyńska J; Szydłowska E; Migdał M; Dzierżanowska-Fangrat K
PLoS One; 2021; 16(4):e0249550. PubMed ID: 33793673
[TBL] [Abstract][Full Text] [Related]
14. Viral and Antibody Kinetics of COVID-19 Patients with Different Disease Severities in Acute and Convalescent Phases: A 6-Month Follow-Up Study.
Zhang X; Lu S; Li H; Wang Y; Lu Z; Liu Z; Lai Q; Ji Y; Huang X; Li Y; Sun J; Wu Y; Xu X; Hou J
Virol Sin; 2020 Dec; 35(6):820-829. PubMed ID: 33351168
[TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin (Ig)A seropositivity against SARS-CoV-2 in healthcare workers in Israel, 4 April to 13 July 2020: an observational study.
Lustig Y; Cohen C; Biber A; Jaber H; Becker Ilany Y; Indenbaum V; Amit S; Mandelboim M; Mendelson E; Regev-Yochay G
Euro Surveill; 2021 Dec; 26(48):. PubMed ID: 34857065
[TBL] [Abstract][Full Text] [Related]
16. High SARS-CoV-2 IgG/IGM seroprevalence in asymptomatic Congolese in Brazzaville, the Republic of Congo.
Batchi-Bouyou AL; Lobaloba Ingoba L; Ndounga M; Vouvoungui JC; Mfoutou Mapanguy CC; Boumpoutou KR; Ntoumi F
Int J Infect Dis; 2021 May; 106():3-7. PubMed ID: 33370565
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2-Specific Neutralizing Antibody Responses in Norwegian Health Care Workers After the First Wave of COVID-19 Pandemic: A Prospective Cohort Study.
Trieu MC; Bansal A; Madsen A; Zhou F; Sævik M; Vahokoski J; Brokstad KA; Krammer F; Tøndel C; Mohn KGI; Blomberg B; Langeland N; Cox RJ;
J Infect Dis; 2021 Feb; 223(4):589-599. PubMed ID: 33247924
[TBL] [Abstract][Full Text] [Related]
18. Assessment of Maternal and Neonatal Cord Blood SARS-CoV-2 Antibodies and Placental Transfer Ratios.
Flannery DD; Gouma S; Dhudasia MB; Mukhopadhyay S; Pfeifer MR; Woodford EC; Triebwasser JE; Gerber JS; Morris JS; Weirick ME; McAllister CM; Bolton MJ; Arevalo CP; Anderson EM; Goodwin EC; Hensley SE; Puopolo KM
JAMA Pediatr; 2021 Jun; 175(6):594-600. PubMed ID: 33512440
[TBL] [Abstract][Full Text] [Related]
19. BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.
Lustig Y; Sapir E; Regev-Yochay G; Cohen C; Fluss R; Olmer L; Indenbaum V; Mandelboim M; Doolman R; Amit S; Mendelson E; Ziv A; Huppert A; Rubin C; Freedman L; Kreiss Y
Lancet Respir Med; 2021 Sep; 9(9):999-1009. PubMed ID: 34224675
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and Course of IgA and IgG Antibodies against SARS-CoV-2 in Healthcare Workers during the First Wave of the COVID-19 Outbreak in Germany: Interim Results from an Ongoing Observational Cohort Study.
Reinwald M; Deckert PM; Ritter O; Andresen H; Schreyer AG; Weylandt KH; Dammermann W; Lüth S
Healthcare (Basel); 2021 Apr; 9(5):. PubMed ID: 33922198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
